Bills · H.R. 11045 · Text
Introduced in House
Confirmed from the official record
Our copy of the file on govinfo.gov, saved November 19, 2026. Fingerprint (SHA-256): 81327ed71b904375.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 11045 Introduced in House (IH)]
<DOC>
119th CONGRESS
2d Session
H. R. 11045
To amend the 21st Century Cures Act and the Public Health Service Act
to ensure that expenses relating to the acquisition or use of devices
for use in the detection of fentanyl, xylazine, and other emerging
adulterant substances, including test strips, are allowable expenses
under certain grant programs.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
November 17, 2026
Mr. Gottheimer (for himself, Mr. Lawler, and Mr. Bacon) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To amend the 21st Century Cures Act and the Public Health Service Act
to ensure that expenses relating to the acquisition or use of devices
for use in the detection of fentanyl, xylazine, and other emerging
adulterant substances, including test strips, are allowable expenses
under certain grant programs.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Preventing Overdoses with Test
Strips Act''.
SEC. 2. AMENDING THE 21ST CENTURY CURES ACT TO AUTHORIZE THE USE OF
FUNDS FOR DEVICES FOR USE IN THE DETECTION OF FENTANYL,
XYLAZINE, AND OTHER EMERGING ADULTERANT SUBSTANCES.
Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee-3a) is
amended--
(1) in subsection (b)(4), by adding at the end the
following:
``(G) Providing assistance for expenses relating to
the acquisition or use of adulterant substance
detection devices.''; and
(2) in subsection (h)--
(A) by redesignating paragraphs (1) through (4) as
paragraphs (2) through (5), respectively; and
(B) by inserting before paragraph (2) (as so
redesignated), the following:
``(1) Adulterant substance detection device.--The term
`adulterant substance detection device' means a device,
including a test strip, that can detect the presence of an
adulterant, such as fentanyl, xylazine, or another adulterant,
in a drug sample prior to use of a controlled substance.''.
SEC. 3. AMENDING THE PUBLIC HEALTH SERVICE ACT TO AUTHORIZE THE USE OF
FUNDS FOR DEVICES FOR USE IN THE DETECTION OF FENTANYL,
XYLAZINE, AND OTHER EMERGING ADULTERANT SUBSTANCES.
Part A of title V of the Public Health Service Act (42 U.S.C. 290aa
et seq.) is amended by adding at the end the following:
``SEC. 506B. USE OF FUNDS FOR DEVICES FOR USE IN THE DETECTION OF
FENTANYL, XYLAZINE, AND OTHER EMERGING ADULTERANT
SUBSTANCES.
``(a) In General.--Expenses relating to the acquisition or use of
adulterant substance detection devices shall be allowable expenses
under any grant, contract, or cooperative agreement entered into by the
Substance Abuse and Mental Health Services Administration under this
Act.
``(b) Definition.--In this section, the term `adulterant substance
detection device' means a device, including a test strip, that can
detect the presence of an adulterant, such as fentanyl, xylazine, or
another adulterant, in a drug sample prior to use of a controlled
substance.''.
<all>